See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Natural Disasters
Baseball
Donald Trump
Social Media
Trade War
Artificial Intelligence
Education
Nintendo
Stock Markets
Senate
Published • loading... • Updated

StockTake: Bioxyne's deal to boost supply pipeline

Summary by Stockhead
Bioxyne (ASX:BXN) has secured a multi-million dollar deal, boosting its position as a leading manufacturer of alternative pharmaceuticals and cannabis-based products.  The new deal is expected to generate $7 million in sales from NectarTek in financial year 2026, a 200 per cent increase on past orders. Watch the video to hear more.   This video was developed in collaboration with Bioxyne, a Stockhead advertiser at the time of publishing. This vi…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
StockheadStockhead

StockTake: Bioxyne's deal to boost supply pipeline

Bioxyne (ASX:BXN) has secured a multi-million dollar deal, boosting its position as a leading manufacturer of alternative pharmaceuticals and cannabis-based products.  The new deal is expected to generate $7 million in sales from NectarTek in financial year 2026, a 200 per cent increase on past orders. Watch the video to hear more.   This video was developed in collaboration with Bioxyne, a Stockhead advertiser at the time of publishing. This vi…

Read Full Article
CannabizCannabiz

Bioxyne inks $7m deal with NectarTek Australia

Breathe Life Sciences (BLS) parent Bioxyne has signed a manufacturing and supply agreement with existing customer, […] The post Bioxyne inks $7m deal with NectarTek Australia appeared first on Cannabiz.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cannabiz broke the news in on Wednesday, April 2, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pharma

Pharma

Australia

Australia

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal